 | | | | The U.S. State Department said on Monday it would start updating this week travel advisories in light of the COVID-19 pandemic's "unprecedented risk to travelers," significantly increasing the number of countries it advises Americans not to visit. | | | | | | New cases of COVID-19 in the United States fell 0.4% last week after rising for four weeks in a row, according to a Reuters analysis of state and county data. | | | | | | Switzerland expanded its capacity to inoculate people against COVID-19 on Monday, opening mass vaccination centres in cities including Geneva and Lausanne. | | | | | | The French health ministry said on Monday that 5,970 people were in intensive care units with COVID-19, up from 5,893 a day earlier, a sign that the hospital system remains under pressure. | | | | | | Mexico's health ministry on Monday reported 1,308 new confirmed cases of COVID-19 in the country and 127 more fatalities, bringing its total to 2,306,910 infections and 212,466 deaths. | | | | | | The coronavirus pandemic saw a traditional Swiss annual rite of spring, the burning of the Boeoegg snowman, moved to the remote Devil's Bridge in central Switzerland on Monday to deter crowds, the first time it has taken place outside Zurich. | | | | | | (Reuters) - Four drugmakers are set to face trial on Monday in a lawsuit by several large counties in California that are seeking more than $50 billion over claims the companies helped fuel an opioid epidemic by deceptively marketing addictive painkillers. | | | | | | Resuming the use of Johnson & Johnson's (JNJ.N) COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as well as alerting vaccine recipients to be aware of the telltale symptoms, according to heart doctors and other medical experts. | | | | | | (Reuters) - The United States is reviewing reports of a handful of potential cases of severe side effects among people who received Johnson & Johnson's COVID-19 vaccine in addition to those that led to a pause in its use, a top U.S. public health official said on Monday. | | | | | | Production of Johnson & Johnson's (JNJ.N) COVID-19 vaccine at a U.S. manufacturing plant was halted by the U.S. Food and Drug Administration while the agency investigates an error that led to millions of doses being ruined last month. | | | | | |
